Global pharmaceutical giant Pfizer has entered into a strategic partnership with Indian pharma major Cipla to jointly market four of its key brands in India. The collaboration aims to leverage Cipla’s robust domestic distribution network and Pfizer’s established product portfolio to enhance market penetration, drive sales growth, and improve accessibility of essential medicines. Industry analysts view the pact as a strategic alignment that strengthens both companies’ competitive positioning in a rapidly expanding healthcare market.